WaveMan
WaveMan · Company
AGBK · Agi Inc
> Search tickers & screens ⌘K
LIVE
← All companies

AGBK AGI (AGBK) Insider Trading, Ownership & Congress Trades

Banks · Commercial banks, nec · CIK 0002081206
Cluster · 7 insidersC-suite buying · 7
House members buying, 1 year
0
STOCK Act, US House only, disclosed up to 45 days after the trade
Funds added, last quarter
21
13F, latest reported quarter

What the filings say about AGBK

Insiders, 180 days
-$2.8M net sold
7 buyers · 1 seller · 0% of sales under a 10b5-1 plan

AGI insider trades (Form 4)

Form 4 buys and sells (codes P and S). Grants, option exercises and conversions excluded.

Over the last 180 days, AGI Inc insiders sold a net $2.8M of stock across 10 Form 4 purchases and sales, with 7 insiders buying. Source: SEC Form 4 filings, as of 2026-10-28.

Insider
Filed
Shares
Value
Since filing
Chief Technology Officer
SELL
2026-09-02 SECtraded 2026-08-31
256,386
$3.1M
-28.8%
Context
  • 1 earlier Form 4 trade (code P or S) here by this insider (1 buy), the last on May 12, 2026.
  • The trade is 145.3% of the 176,423 shares held after it.
  • No other insider sold within 30 days.
  • 21 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Chief Technology Officer ALOE VINICIUS BIRKELAND sold about $3.1M of AGBK on Aug 31, 2026, the largest insider sale at the company on our record; 21 funds added in the latest 13F quarter.
Chief Technology Officer
SELL
2026-09-02 SECtraded 2026-08-31
406
$2.4K
-28.8%
Context
  • 1 earlier Form 4 trade (code P or S) here by this insider (1 buy), the last on May 12, 2026.
  • No other insider sold within 30 days.
  • 21 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Chief Technology Officer ALOE VINICIUS BIRKELAND sold about $2.4K of AGBK on Aug 31, 2026, the largest insider sale at the company on our record; 21 funds added in the latest 13F quarter.
Chief Products Officer
BUY
2026-06-03 SEC
100
$690
-28.8%
Context
  • 1 earlier Form 4 trade (code P or S) here by this insider (1 buy), the last on May 7, 2026.
  • The trade is 100.0% of the 100 shares held after it.
  • 6 other insiders bought within 30 days.
  • 21 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Chief Products Officer De Farias Daniel Monteiro bought about $690 of AGBK on Jun 3, 2026; 6 other insiders bought within 30 days and 21 funds added in the latest 13F quarter.
Director and COO
BUY
2026-06-02 SECtraded 2026-06-01
2,000
$14.7K
-27.8%
Context
  • First Form 4 purchase or sale (code P or S) here by this insider on our record.
  • The trade is 100.0% of the 2,000 shares held after it.
  • 6 other insiders bought within 30 days.
  • 21 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director and COO Correa Glauber Marques bought about $14.7K of AGBK on Jun 1, 2026; 6 other insiders bought within 30 days and 21 funds added in the latest 13F quarter.
Financial and IR Officer
BUY
2026-05-20 SECtraded 2026-05-19
1,000
$7.0K
-31.9%
Context
  • First Form 4 purchase or sale (code P or S) here by this insider on our record.
  • The trade is 100.0% of the 1,000 shares held after it.
  • 6 other insiders bought within 30 days.
  • 21 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Financial and IR Officer DUBEUX MARCELLO WINIK bought about $7.0K of AGBK on May 19, 2026; 6 other insiders bought within 30 days and 21 funds added in the latest 13F quarter.
10 transactions on record
Since filing: total return from the first close after the filing to the latest close, dividend-adjusted. Not a forecast.
Context lines are counts over the filings above and returns from our own price history, never a price level. Not investment advice.
Showing the latest few. to see 5 more transactions and use the screener and CSV export. We store only your email; there is no password.
Seven facts, ranked against the sector · Rank is not a forecast
Insiders
net -$2.8M over 180 days
-$3.1M over 90 days
below 84% of Banks
Congress
no House purchase disclosed in the last 12 months
Funds
21 funds bought in last quarter
below 90% of Banks
Revenue
no revenue reported in any filing
Margin
no margin: no revenue reported
Buybacks
no share repurchases reported
Short interest
3.9% of the float short (float per yahoo 2026-10-27) · 2.0 days to cover · settled 2026-10-15
What changed in the last 30 days
Oct 28Insider buying stopped: no purchases in 90 days after 8 in the prior 90
Why it matters
The absence is the signal: 8 purchases in one 90-day window and none in the next is a change of behaviour, not a filing.

Watch AGBK

A free account keeps a watchlist and can send one email a day when insiders, funds or Congress file on the names in it. No password and no card.

The year, with the filings on it
Total return over 12 months. Each marker is a filing; hover or tap one for the detail.
-54.6%12M
-56%-33%-11%+12%2026-022026-032026-052026-062026-072026-092026-10 2026-08-31 · ALOE VINICIUS BIRKELAND sold $3.1M2026-05-07 · TESTA MARCIANO bought $200.2K2026-06-01 · Correa Glauber Marques bought $14.7K2026-05-19 · DUBEUX MARCELLO WINIK bought $7.0K2026-05-07 · De Farias Daniel Monteiro bought $5.0K2026-05-14 · Morais Rafael De Oliveira bought $3.1K2026-05-12 · ALOE VINICIUS BIRKELAND bought $3.0K2026-08-31 · ALOE VINICIUS BIRKELAND sold $2.4K2026-05-08 · GIRARDI MATHEUS bought $1.9K2026-06-03 · De Farias Daniel Monteiro bought $690
Insider buyInsider sell
Indexed to 100, dividend-adjusted, not a price chart. When a name files heavily, the largest trades are drawn first.

Who owns AGBK: institutional holders (13F)

13F holdings, latest reported quarter
2,343,229 sh
$16.6M
$15.8M
1,530,361 sh
$10.8M
1,250,000 sh
$8.8M

Congress trades in AGBK

No Congress trades reported
No House member has disclosed a trade in this stock. See what Congress is buying.

Activist and 5% holders (13D/13G)

No 5%+ ownership filings
Nobody has filed for crossing 5%. That is a fact, not missing data.

AGBK planned insider sales (Form 144)

No planned-sale notices
No insider has filed to sell. Watch this after a run-up.

AGBK mutual fund holders (N-PORT)

Funds ranked by the share of their own portfolio in this stock (N-PORT).
JOHCM Emerging Markets Discovery Fund
$382.3K position · as of 2026-06-30
0.4%
Disciplined Value Emerging Markets Equity Fund
$212.3K position · as of 2026-05-31
0.1%
Disciplined Value Emerging Markets Equity Trust
$429.0K position · as of 2026-06-30
0.1%
Small Cap Core Fund
$105.7K position · as of 2026-06-30
0.0%
SEC N-PORT, monthly, about 60 days late · funds ≥ $10M · % is the share of the fund's own portfolio
Live price
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
7 insiders reported buying shares.
The record shows a net $2.8M sold by insiders over 180 days, 21 funds added last quarter. Each figure is a federal filing, dated the day it went public.
Same sector, ranked by filing activity
Sector by SEC SIC code

AGBK Stock Sonar score 3/7 axes

Find similar shapesCompare

AGBK ranks highest on insider conviction (56th percentile) and risk and compliance (41st), and lowest on institutional and government (10th), among Banks peers.

Insider conviction
56
Inputs
  • Net Form 4 buying (codes P and S), 180d-$2.8M · 16 pct, sector of 273
  • Insider buyers, 180d7 · 96 pct, sector of 273
Institutional and government
10
Inputs
  • Funds adding, latest quarter21 · 10 pct, sector of 257
  • Congress net buyers, 365dno Congress trades in 365 days
  • Federal contracts, 180dno federal contracts in 180 days
  • Lobbying spend, 4 quartersno lobbying filings in the last four quarters
Risk and compliance
41
Inputs
  • Short interest, % of float+3.9% · 41 pct, sector of 374
  • Recalls per $1B revenue, 3yrevenue under $50M or not filed, so a count cannot be scaled to size
  • EPA cases per $1B revenue, 5yrevenue under $50M or not filed, so a count cannot be scaled to size
  • New text in Risk Factors, latest 10-Kneeds two 10-Ks with a Risk Factors section (not 20-F filers or stubs)
4 not measured: Profitability, Financial health, Growth, US patents
  • Profitability needs 2 of 4 inputs, 0 present: not filed
  • Financial health needs 1 of 2 inputs, 0 present: not filed
  • Growth needs 1 of 2 inputs, 0 present: no backlog line filed, or no year-earlier backlog; no revenue for this year and the year before
  • US patents needs 1 of 2 inputs, 0 present: patent data not loaded yet

3 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored

AGBK filings, in plain words

Are AGI insiders buying or selling AGBK?

In the 180 days to 2026-10-28, AGI insiders were net sellers, a net $2.8M: $235.6K of purchases and $3.1M of sales reported on Form 4, by 7 buyers and 1 seller.

Read the full summary

In the 180 days to 2026-10-28, AGI insiders were net sellers of AGBK, a net $2.8M across purchases and sales reported on Form 4 by 7 buyers and 1 seller. Sales outweighed purchases more than tenfold by value. 7 insiders reported purchases in that window. Each figure is counted from SEC and House filings as of 2026-10-28, dated the day the filing was made public.

Explore insider trading and ownership data

Every company we track, ranked by each kind of filing